Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.
A local melanocortin system is active during tissue injury and inflammation. Thus far this system has been described as autocrine in nature where local production of pro-opiomelanocortin (POMC) peptides by leukocytes feeds back on melanocortin receptor (MC-R) expressing immune cells to quell inflammatory cytokine production. Here we present evidence that POMC peptides may generate extracellular matrix (ECM) changes by inducing matrix production by cells of the mesenchymal lineage through activation of the MC2-R. Using immunoblot, we determined that mouse aorta-derived mesenchymal progenitor cells express both MC2-R and MC3-R. These progenitors respond to treatment with ACTH by increasing collagen matrix synthesis as assessed by picrosirius red stain and (3)H-proline incorporation. ACTH also induces transient increases in intracellular calcium ([Ca(2+)](i)) as assessed using the fluorescent Ca(2+) indicator, fura-2. The ACTH-induced changes in [Ca(2+)](i) are consistent with MC2-R signaling and consist of both an intracellular release and an extracellular influx of Ca(2+). Both mouse aortic mesenchymal progenitors and mouse macrophage cells express POMC and the prohormone convertase 1/3 (PC1/3) indicating they have the potential to contribute to the local production of POMC peptides. These data demonstrate functional MC2-R expression in mouse aorta-derived mesenchymal progenitors and implicate both macrophage and mesenchymal cells as relevant sources of local POMC peptides.
Biomedical Research Core, Winthrop University Hospital, Mineola, NY 11501, United States. jevans@winthrop.org
Jodi F
JF
Evans
Anne
A
Fernando
Louis
L
Ragolia
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D001391:Azo Compounds; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D003094:Collagen / Q000235:genetics / Q000378:metabolism; D005109:Extracellular Matrix / Q000187:drug effects; D016257:Fura-2; D015870:Gene Expression / Q000187:drug effects; D008264:Macrophages / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D011333:Pro-Opiomelanocortin / Q000235:genetics / Q000378:metabolism; D045664:Proprotein Convertase 1 / Q000235:genetics / Q000378:metabolism; D051381:Rats; D011921:Rats, Inbred WKY; D044103:Receptor, Melanocortin, Type 2 / Q000235:genetics / Q000378:metabolism*; D044104:Receptor, Melanocortin, Type 3 / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects
D001391:Azo Compounds; D044103:Receptor, Melanocortin, Type 2; D044104:Receptor, Melanocortin, Type 3; C009798:C.I. direct red 80; D011333:Pro-Opiomelanocortin; D000324:Adrenocorticotropic Hormone; D003094:Collagen; D045664:Proprotein Convertase 1; D002118:Calcium; D016257:Fura-2